Diseases

Monoclonal gammopathies of clinical significance

9 papers and 5 abstracts co-authored by Raphael E. Szalat. Current lab members are shown in bold.

Papers 9

  1. 2022

    Prevalence of monoclonal gammopathy of undetermined significance in US black women

    Bertrand KA, Zirpoli G, Pillalamarri BN, Szalat R, Palmer JR, Kataria Y

    American Journal of Hematology97(9)DOI: Prevalence of monoclonal gammopathy of undetermined significance in US black womenPubMed: Prevalence of monoclonal gammopathy of undetermined significance in US black women

  2. 2017

    Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell lines

    Maura F, Petljak M, Lionetti M, …, Szalat R, …, Bolli N

    Leukemia32(4):1043-1047DOI: Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell linesPubMed: Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell lines

  3. 2017

    Non‐cirrhotic portal hypertension in necrobiotic xanthogranuloma associated with monoclonal gammopathy

    Vignon M, Placais L, Malphettes M, …, Szalat R, …, Arnulf B

    Journal of the European Academy of Dermatology and Venereology31(9)DOI: Non‐cirrhotic portal hypertension in necrobiotic xanthogranuloma associated with monoclonal gammopathyPubMed: Non‐cirrhotic portal hypertension in necrobiotic xanthogranuloma associated with monoclonal gammopathy

  4. 2015

    Bortezomib produces high hematological response rates with prolonged renal survival in monoclonal immunoglobulin deposition disease

    Cohen C, Royer B, Javaugue V, Szalat R, …, Bridoux F

    Kidney International88(5):1135-1143DOI: Bortezomib produces high hematological response rates with prolonged renal survival in monoclonal immunoglobulin deposition diseasePubMed: Bortezomib produces high hematological response rates with prolonged renal survival in monoclonal immunoglobulin deposition disease

  5. 2015

    The spectrum of neutrophilic dermatoses associated with monoclonal gammopathy: Association with IgA isotype and inflammatory profile

    Szalat R, Monsel G, Le Goff W, …, Asli B

    Journal of the American Academy of Dermatology73(5):809-820DOI: The spectrum of neutrophilic dermatoses associated with monoclonal gammopathy: Association with IgA isotype and inflammatory profilePubMed: The spectrum of neutrophilic dermatoses associated with monoclonal gammopathy: Association with IgA isotype and inflammatory profile

  6. 2014

    Clinico‐biological characteristics and treatment of type I monoclonal cryoglobulinaemia: a study of 64 cases

    Harel S, Mohr M, Jahn I, …, Szalat R, …, Fermand J

    British Journal of Haematology168(5):671-678DOI: Clinico‐biological characteristics and treatment of type I monoclonal cryoglobulinaemia: a study of 64 casesPubMed: Clinico‐biological characteristics and treatment of type I monoclonal cryoglobulinaemia: a study of 64 cases

  7. 2014

    Physiopathology of necrobiotic xanthogranuloma with monoclonal gammopathy

    Szalat R, Pirault J, Fermand J‐, …, Goff WL

    Journal of Internal Medicine276(3):269-284DOI: Physiopathology of necrobiotic xanthogranuloma with monoclonal gammopathyPubMed: Physiopathology of necrobiotic xanthogranuloma with monoclonal gammopathy

  8. 2013

    Manifestations cutanées révélant une cryofibrinogénémie associée à une gammapathie monoclonale

    Delyon J, Bezier M, Cordoliani F, Malphettes M, Szalat R, Bagot M, Rybojad M

    Annales de Dermatologie et de Vénéréologie140(1):30-35DOI: Manifestations cutanées révélant une cryofibrinogénémie associée à une gammapathie monoclonalePubMed: Manifestations cutanées révélant une cryofibrinogénémie associée à une gammapathie monoclonale

  9. 2011

    Pathogenesis and treatment of xanthomatosis associated with monoclonal gammopathy

    Szalat R, Arnulf B, Karlin L, …, Fermand JP

    Blood118(14):3777-3784DOI: Pathogenesis and treatment of xanthomatosis associated with monoclonal gammopathyPubMed: Pathogenesis and treatment of xanthomatosis associated with monoclonal gammopathy

Abstracts & posters 5

  1. 2024

    Disparities in Monoclonal Immunoglobulin-Associated Disorders in a Large and Diverse Cohort from a US Tertiary Safety-Net Center

    Aijaz A, Szalat RE

    Blood144(Supplement 1):6899-6899DOI: Disparities in Monoclonal Immunoglobulin-Associated Disorders in a Large and Diverse Cohort from a US Tertiary Safety-Net Center

  2. 2024

    Epidemiological Characteristics and Clinical Outcomes of Patients with Monoclonal Gammopathy of Renal Significance (MGRS) Diagnosed in a Large Safety-Net Hospital in the US

    Granina E, Henderson J, Bertrand KA, Sanchorawala V, Szalat RE

    Blood144(Supplement 1):4680-4680DOI: Epidemiological Characteristics and Clinical Outcomes of Patients with Monoclonal Gammopathy of Renal Significance (MGRS) Diagnosed in a Large Safety-Net Hospital in the US

  3. 2024

    Epidemiology and clinical characteristics of patients with monoclonal gammopathy of renal significance (MGRS) in a diverse population

    Granina E, Henderson J, Bertrand K, Sanchorawala V, Szalat R

    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS31:S135-S135

  4. 2015

    Étude nationale observationnelle des cutis laxa associées à une gammapathie monoclonale

    Saussine A, Bouaziz JD, Asli B, …, Szalat R, …, Rybojad M

    Annales de Dermatologie et de Vénéréologie142(12):S482-S483DOI: Étude nationale observationnelle des cutis laxa associées à une gammapathie monoclonale

  5. 2013

    Dermatoses neutrophiliques et gammapathies monoclonales : 26 cas et revue de la littérature

    Monsel G, Szalat R, Battistella M, Vignon-Pennamen MD, Bagot M, Fermand JP, Asli B, Rybojad M

    Annales de Dermatologie et de Vénéréologie140(12):S605DOI: Dermatoses neutrophiliques et gammapathies monoclonales : 26 cas et revue de la littérature